Answers are grounded in this paper and cite their sources.
Background and Objectives: The i-gel is a second-generation supraglottic airway device that may be suitable for repeated airway management during awake craniotomy (AC) using the asleep–awake–asleep (AAA) technique. This study evaluated the feasibility of using the i-gel for airway management during AC. Materials and Methods: This single-center retrospective study included 366 patients in whom AC for brain tumor resection using the AAA technique was planned. The primary outcome was the overall success rate of i-gel-only airway management. Secondary outcomes included success rates during each asleep phase, rescue airway strategies, airway-related adverse events, and factors associated with second-phase failure. Results: Initial-phase i-gel management was successful in 363/366 patients (99.2%). Among these 363 patients, second-phase i-gel management was successful in 345 (95.0%). Overall, both asleep phases were completed using the i-gel alone in 345/366 patients (94.3%). Of the 18 second-phase failures, 10 involved inadequate ventilation despite successful insertion, and eight involved difficult or failed reinsertion. Rescue airway management was successful in all 18 patients, including seven patients who underwent fiberoptic-guided tracheal intubation through the i-gel. No severe hypoxemia or clinically significant airway injury occurred. Initial suboptimal i-gel fit was associated with second-phase failure (adjusted odds ratio, 7.05; 95% confidence interval, 2.58–18.97; p < 0.001). Conclusions: The i-gel provided successful airway management in most patients undergoing AC with the AAA technique. An initially suboptimal fit may serve as a warning signal for second-phase failure, and appropriate rescue airway strategies should be readily available.
No takes yet. Share an insight, caveat, or question.
Somura et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: